07.04.2017 23:19:00

Muskingum University Installs Dr. Susan S. Hasseler As Its 21st President

NEW CONCORD, Ohio, April 7, 2017 /PRNewswire-USNewswire/ -- This afternoon, Muskingum University's campus community, trustees, alumni and distinguished guests gathered to formally install Dr. Susan S. Hasseler as the University's 21st president. In her address, Dr. Hasseler emphasized the University's long-standing history of community engagement, service and exploration, and shared a vision of the future focused on expanded investments in student success and creating new opportunities and experiences for students.

"It takes the whole community to educate the whole person for the whole world. This Muskingum University community, as it has done throughout its history, takes to heart that promise to our students," Dr. Hasseler said. "As we honor our University's past and we look forward to its dynamic future, we keep envisioning the ways in which the student experience will continue to evolve, just as the world will continue to evolve."

Dr. Hasseler highlighted an expansion of the University's presence and partnerships in the region and beyond, seeking new opportunities for Muskingum students, faculty, and staff to learn with and from the communities that surround it. She also committed to a continual focus on relevance and responsiveness, honing the University's culture of entrepreneurial thinking and innovative educational programs that prepare students for an ever-changing future.

"We will encourage our students to have the courage to take risks, to address challenges, to grapple with complex problems and ideas, to embrace ambiguity, to persist in the face of disappointment, to seek justice and to soar," Dr. Hasseler said. "And we will teach them that they will find their purpose by engaging with and serving others."

The inaugural convocation was part of a week of activities showcasing the talents and achievements of students throughout campus and engaging the University's surrounding communities. The events included the inaugural lecture in The John Glenn Distinguished Lecture Series in Earth and Planetary Sciences, featuring guest speaker Dr. Scott E. Parazynski, an astronaut and former crewmate of the late Senator John Glenn.

"Each of us in this room has been called to Muskingum," Dr. Hasseler said. "We have been called to build on our strong foundation, to sustain our community, to lead and to serve with courage, and to continue to help our students discover their own deep gladness and the world's deep hunger, so that they may create their own profound impact on the world."

For more information about Dr. Hasseler, visit muskingum.edu/president.

ABOUT MUSKINGUM UNIVERSITY
Founded in 1837, Muskingum University educates the whole student for the whole world. Committed to excellence, affordability, and innovation, it was ranked the #5 Best Value in midwest regional universities by U.S. News and World Report in its 2017 Best Colleges guide. Muskingum offers more than 60 undergraduate majors which prepare students for the professional workforce and advanced studies; three master's degree programs; the Muskingum Adult Program featuring online and evening courses; and workforce development partnerships for continuing education. Emphasizing entrepreneurial and experiential learning opportunities on its campus, in the community, and around the world, Muskingum is located in the village of New Concord, an hour east of Columbus on Interstate 70. Muskingum's excellence is measured most significantly by its alumni, who have served the world as CEOs of major corporations, major media figures, scientists, educators, civic and religious leaders, and as parents and friends. For more information, visit muskingum.edu.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/muskingum-university-installs-dr-susan-s-hasseler-as-its-21st-president-300436803.html

SOURCE Muskingum University

Nachrichten zu Clovis Oncology Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Clovis Oncology Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Kandi Technologies Corp 2,00 5,71% Kandi Technologies Corp
Ligand Pharmaceuticals Inc 109,00 0,93% Ligand Pharmaceuticals Inc